Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC-ND 4.0Journal of Medical Case Reports

Probable isolated ocular surface blood transfusion reaction in a patient with advanced prostate cancer: a case report

5 affiliations
  1. 1Oncology Unit, Adama Hospital Medical College, Adama, Ethiopia
  2. 2Laboratory For Molecular Virology and Gene Therapy, Department of Pharmaceutical and Pharmaceutical Sciences, KU Leuven, Louvain, Belgium
  3. 3Tikur Anbessa Specialized Hospital Addis Ababa, Addis Ababa, Ethiopia
  4. 4Hennepin Healthcare, Minneapolis, MN USA
  5. 5Department of Haematology and Blood Transfusion, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria

Abstract

Background: Cancer treatments, such as surgery, chemotherapy, and radiotherapy, as well as cancer itself, commonly result in anemia. As a result, patients frequently require blood transfusions to maintain an optimal hemoglobin level. However, blood transfusion has its own set of adverse reactions, which can range from minor to life-threatening complications, such as hemolytic transfusion reaction, transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO). The exact incidence of transfusion reactions in cancer patients is not well-known. In earlier reports, the overall incidence is 0.3%. However, to the best of the author’s knowledge, there is no published report of isolated ocular blood transfusion reaction in Ethiopia. Here, we report the presentation of an infrequent adverse event and its management.

Case presentation: A 51-year-old man with castration-resistant prostate cancer and severe anemia (hemoglobin concentration of 6.2 g/dl). Packed red-cell transfusion was started after grouping and cross-matching. After about 250 ml of the blood had been transfused, he suddenly felt severe pain and discomfort in both eyes, with associated photophobia and conjunctival edema. Ocular examination revealed edematous and engorged conjunctivae with thick mucinous coverage. The rest of the examinations were non-revealing. Based on the absence of fever, chills, hypotension, respiratory distress, abdominal pain, jaundice, or change in the urine color on this presentation, acute hemolytic transfusion reaction, TACO, and TRALI were considered clinically unlikely. Transfusion was immediately discontinued; intravenous and topical steroid was applied. Signs and symptoms resolved completely within 8 h and was discharged home the following day after observation.

Conclusions: We have reported a probable case of isolated ocular surface blood transfusion reaction. Despite the fact that this complication is extremely rare. Prompt discontinuation of transfusion and administration of systemic and topical steroids led to rapid resolution; however, no standardized protocol exists for this rare entity.

Related

  1. Primary pulmonary MALT lymphoma with probable isolated light chain deposition disease: Case report and literature review
    Rachad Elghoul, Lucas Weingartz, Fateh Hayat +2
    Radiology case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCEurope PMCPMC
  2. Acute diarrhea following the first subcutaneous dose of tafolecimab: a case report of a probable adverse drug reaction
    Jie He
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  3. Multi-Agent Generative Artificial Intelligence for Transfusion Reaction Feature Extraction
    A. Kumari, J. W. Jacobs, L. Dilly +12
    medRxivPreprintCC BY-NC-NDFull textEpidemiology & public healthmedRxiv
  4. Diagnostic Nuances in Isolated Hepatic Sarcoidosis: Sarcoid-like Reaction and Needle Selection
    Koji Takahashi
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  5. Response to the Letter to the Editor Entitled "Diagnostic Nuances in Isolated Hepatic Sarcoidosis: Sarcoid-like Reaction and Needle Selection"
    Hideho Honda, Hiroto Tanoue, Haruka Goda +5
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
BibTeX
@article{deressa2026probable,
  title = {{Probable isolated ocular surface blood transfusion reaction in a patient with advanced prostate cancer: a case report}},
  author = {Biniyam Tefera Deressa and Thatcher Zinabu Akele and Wasie Gebi and Girum Tessema Zingeta and Ibrahim Oluwaseun Ahmed},
  journal = {Journal of Medical Case Reports},
  year = {2026},
  month = aug,
  doi = {10.1186/s13256-026-06474-1},
  url = {https://doi.org/10.1186/s13256-026-06474-1},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Probable isolated ocular surface blood transfusion reaction in a patient with advanced prostate cancer: a case report
AU  - Biniyam Tefera Deressa
AU  - Thatcher Zinabu Akele
AU  - Wasie Gebi
AU  - Girum Tessema Zingeta
AU  - Ibrahim Oluwaseun Ahmed
PY  - 2026
DA  - 2026/08/16
JO  - Journal of Medical Case Reports
DO  - 10.1186/s13256-026-06474-1
UR  - https://doi.org/10.1186/s13256-026-06474-1
AB  - Background: Cancer treatments, such as surgery, chemotherapy, and radiotherapy, as well as cancer itself, commonly result in anemia. As a result, patients frequently require blood transfusions to maintain an optimal hemoglobin level. However, blood transfusion has its own set of adverse reactions, which can range from minor to life-threatening complications, such as hemolytic transfusion reaction, transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO). The exact incidence of transfusion reactions in cancer patients is not well-known. In earlier reports, the overall incidence is 0.3%. However, to the best of the author’s knowledge, there is no published report of isolated ocular blood transfusion reaction in Ethiopia. Here, we report the presentation of an infrequent adverse event and its management.  Case presentation: A 51-year-old man with castration-resistant prostate cancer and severe anemia (hemoglobin concentration of 6.2 g/dl). Packed red-cell transfusion was started after grouping and cross-matching. After about 250 ml of the blood had been transfused, he suddenly felt severe pain and discomfort in both eyes, with associated photophobia and conjunctival edema. Ocular examination revealed edematous and engorged conjunctivae with thick mucinous coverage. The rest of the examinations were non-revealing. Based on the absence of fever, chills, hypotension, respiratory distress, abdominal pain, jaundice, or change in the urine color on this presentation, acute hemolytic transfusion reaction, TACO, and TRALI were considered clinically unlikely. Transfusion was immediately discontinued; intravenous and topical steroid was applied. Signs and symptoms resolved completely within 8 h and was discharged home the following day after observation.  Conclusions: We have reported a probable case of isolated ocular surface blood transfusion reaction. Despite the fact that this complication is extremely rare. Prompt discontinuation of transfusion and administration of systemic and topical steroids led to rapid resolution; however, no standardized protocol exists for this rare entity.
SN  - 1752-1947
ER  -